Mitochondrial oxidative stress, mitochondrial ROS storms in long COVID pathogenesis

Significance This review discusses the coronavirus disease 2019 (COVID-19) pathophysiology in the context of diabetes and intracellular reactions by COVID-19, including mitochondrial oxidative stress storms, mitochondrial ROS storms, and long COVID. Recent advances The long COVID is suffered in ~10% of the COVID-19 patients. Even the virus does not exist, the patients suffer the long COVID for even over a year, This disease could be a mitochondria dysregulation disease. Critical issues Patients who recover from COVID-19 can develop new or persistent symptoms of multi-organ complications lasting weeks or months, called long COVID. The underlying mechanisms involved in the long COVID is still unclear. Once the symptoms of long COVID persist, they cause significant damage, leading to numerous, persistent symptoms. Future directions A comprehensive map of the stages and pathogenetic mechanisms related to long COVID and effective drugs to treat and prevent it are required, which will aid the development of future long COVID treatments and symptom relief.

[1]  A. Murueta-Goyena,et al.  Dysautonomia and small fiber neuropathy in post-COVID condition and Chronic Fatigue Syndrome , 2023, Journal of Translational Medicine.

[2]  Weiwei Xia,et al.  Mitochondrial antiviral signaling protein: a potential therapeutic target in renal disease , 2023, Frontiers in immunology.

[3]  Larry N. Singh,et al.  Core mitochondrial genes are down-regulated during SARS-CoV-2 infection of rodent and human hosts , 2023, Science Translational Medicine.

[4]  R. Mandal,et al.  The plasma metabolome of long COVID patients two years after infection , 2023, Scientific reports.

[5]  David M. Liebovitz,et al.  Outpatient treatment of COVID-19 and incidence of post-COVID-19 condition over 10 months (COVID-OUT): a multicentre, randomised, quadruple-blind, parallel-group, phase 3 trial , 2023, The Lancet Infectious Diseases.

[6]  Tsung-Hsien Chen,et al.  Possible Pathogenesis and Prevention of Long COVID: SARS-CoV-2-Induced Mitochondrial Disorder , 2023, International journal of molecular sciences.

[7]  F. Taghizadeh-Hesary,et al.  COVID-19 induced liver injury from a new perspective: Mitochondria , 2023, Mitochondrion.

[8]  D. Colangelo,et al.  COVID-19 Biomarkers at the Crossroad between Patient Stratification and Targeted Therapy: The Role of Validated and Proposed Parameters , 2023, International journal of molecular sciences.

[9]  A. Acquaviva,et al.  Decreased Gas6 and sAxl Plasma Levels Are Associated with Hair Loss in COVID-19 Survivors , 2023, International journal of molecular sciences.

[10]  E. Topol,et al.  Long COVID: major findings, mechanisms and recommendations , 2023, Nature Reviews Microbiology.

[11]  T. Zaehle,et al.  The therapeutic potential of non-invasive brain stimulation for the treatment of Long-COVID-related cognitive fatigue , 2023, Frontiers in Immunology.

[12]  K. Thangaraj,et al.  Severe acute respiratory syndrome coronaviruses contributing to mitochondrial dysfunction: Implications for post-COVID complications , 2023, Mitochondrion.

[13]  G. Cappellano,et al.  Determinants of long COVID among adults hospitalized for SARS-CoV-2 infection: A prospective cohort study , 2022, Frontiers in Immunology.

[14]  Julie Dee Bell,et al.  Understanding Long COVID; Mitochondrial Health and Adaptation—Old Pathways, New Problems , 2022, Biomedicines.

[15]  V. Chinchilli,et al.  Association of COVID-19 with diabetes: a systematic review and meta-analysis , 2022, Scientific Reports.

[16]  Rudranil De,et al.  Pathophysiological involvement of host mitochondria in SARS-CoV-2 infection that causes COVID-19: a comprehensive evidential insight , 2022, Molecular and Cellular Biochemistry.

[17]  P. Lotufo,et al.  Post-COVID syndrome, inflammation, and diabetes , 2022, Journal of Diabetes and its Complications.

[18]  D. Colangelo,et al.  CGRP Plasma Levels Correlate with the Clinical Evolution and Prognosis of Hospitalized Acute COVID-19 Patients , 2022, Viruses.

[19]  C. Duan,et al.  SARS-CoV-2 Achieves Immune Escape by Destroying Mitochondrial Quality: Comprehensive Analysis of the Cellular Landscapes of Lung and Blood Specimens From Patients With COVID-19 , 2022, Frontiers in Immunology.

[20]  J. A. Rock,et al.  Diabetes and COVID-19: Short- and Long-Term Consequences , 2022, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[21]  C. Steves,et al.  Risk of long COVID associated with delta versus omicron variants of SARS-CoV-2 , 2022, The Lancet.

[22]  Z. Al-Aly,et al.  Long COVID after breakthrough SARS-CoV-2 infection , 2022, Nature Medicine.

[23]  D. Lilleri,et al.  Baseline Plasma Gas6 Protein Elevation Predicts Adverse Outcomes in Hospitalized COVID-19 Patients , 2022, Disease markers.

[24]  K. Kraft,et al.  Oxidative Stress and Hyper-Inflammation as Major Drivers of Severe COVID-19 and Long COVID: Implications for the Benefit of High-Dose Intravenous Vitamin C , 2022, Frontiers in Pharmacology.

[25]  G. Muscogiuri,et al.  Vitamin D: A Role Also in Long COVID-19? , 2022, Nutrients.

[26]  Yan Xie,et al.  Risks and burdens of incident diabetes in long COVID: a cohort study , 2022, The Lancet Diabetes & Endocrinology.

[27]  D. Lilleri,et al.  Prognostic Markers in Hospitalized COVID-19 Patients: The Role of IP-10 and C-Reactive Protein , 2022, Disease markers.

[28]  P. Pfeffer,et al.  A clinical review of long-COVID with a focus on the respiratory system , 2022, Current opinion in pulmonary medicine.

[29]  Peihui Wang,et al.  SARS-CoV-2 membrane protein causes the mitochondrial apoptosis and pulmonary edema via targeting BOK , 2022, Cell Death & Differentiation.

[30]  G. Lippi,et al.  Blood lactate concentration in COVID-19: a systematic literature review , 2021, Clinical chemistry and laboratory medicine.

[31]  S. Karim,et al.  Omicron SARS-CoV-2 variant: a new chapter in the COVID-19 pandemic , 2021, The Lancet.

[32]  I. Merfort,et al.  Identification of an ASC oligomerization inhibitor for the treatment of inflammatory diseases , 2021, Cell Death & Disease.

[33]  Ling Zhu,et al.  The Triangle Relationship Between Long Noncoding RNA, RIG-I-like Receptor Signaling Pathway, and Glycolysis , 2021, Frontiers in Microbiology.

[34]  J. Lagier,et al.  Long-term persistence of symptoms of dyspnoea in COVID-19 patients , 2021, International Journal of Infectious Diseases.

[35]  M. Farzan,et al.  Mechanisms of SARS-CoV-2 entry into cells , 2021, Nature reviews. Molecular cell biology.

[36]  Meeta Gupta,et al.  A Systematic Review and Meta-analysis of Diabetes Associated Mortality in Patients with COVID-19 , 2021, International journal of endocrinology and metabolism.

[37]  M. Martinez-Fierro,et al.  Mitochondria and Mitochondrial DNA: Key Elements in the Pathogenesis and Exacerbation of the Inflammatory State Caused by COVID-19 , 2021, Medicina.

[38]  S. Snyder,et al.  Redox imbalance links COVID-19 and myalgic encephalomyelitis/chronic fatigue syndrome , 2021, Proceedings of the National Academy of Sciences.

[39]  Ilene S Ruhoy,et al.  Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Essentials of Diagnosis and Management. , 2021, Mayo Clinic proceedings.

[40]  P. Edison,et al.  Long covid—mechanisms, risk factors, and management , 2021, BMJ.

[41]  G. Cui,et al.  Saving critically ill COVID-19 patients with mechanical circulatory support , 2021, Annals of translational medicine.

[42]  S. Safiri,et al.  Potency of BNT162b2 and mRNA‐1273 vaccine‐induced neutralizing antibodies against severe acute respiratory syndrome‐CoV‐2 variants of concern: A systematic review of in vitro studies , 2021, Reviews in medical virology.

[43]  T. Burki Lifting of COVID-19 restrictions in the UK and the Delta variant , 2021, The Lancet Respiratory Medicine.

[44]  J. Gameiro,et al.  Impact of Chronic RAAS Use in Elderly COVID-19 Patients: A Retrospective Analysis , 2021, Journal of clinical medicine.

[45]  V. Pravica,et al.  Immune Evasion of SARS-CoV-2 Emerging Variants: What Have We Learnt So Far? , 2021, Viruses.

[46]  N. Secher,et al.  The role of lactate in sepsis and COVID‐19: Perspective from contracting skeletal muscle metabolism , 2021, Experimental physiology.

[47]  A. Cumpstey,et al.  COVID-19 - A Redox Disease What a Stress Pandemic Can Teach Us About Resilience and What We May Learn from the Reactive Species Interactome About its Treatment. , 2021, Antioxidants & redox signaling.

[48]  R. Jayadevan,et al.  Long COVID: An overview , 2021, Diabetes & Metabolic Syndrome: Clinical Research & Reviews.

[49]  P. Prasun COVID-19: A Mitochondrial Perspective. , 2021, DNA and cell biology.

[50]  R. H. Al-Rifai,et al.  Diabetes prevalence and mortality in COVID-19 patients: a systematic review, meta‐analysis, and meta‐regression , 2021, Journal of Diabetes & Metabolic Disorders.

[51]  D. Brodie,et al.  Post-acute COVID-19 syndrome , 2021, Nature Medicine.

[52]  A. Iwasaki,et al.  The first 12 months of COVID-19: a timeline of immunological insights , 2021, Nature reviews. Immunology.

[53]  David A. Drew,et al.  Attributes and predictors of long COVID , 2021, Nature Medicine.

[54]  S. Valdivieso,et al.  Role of neutrophil-to-lymphocyte, lymphocyte-to-monocyte and platelet-to-lymphocyte ratios as predictors of disease severity in COVID-19 patients. , 2021, Le infezioni in medicina.

[55]  A. Salonia,et al.  Diabetes is most important cause for mortality in COVID-19 hospitalized patients: Systematic review and meta-analysis , 2021, Reviews in Endocrine and Metabolic Disorders.

[56]  A. Pandey,et al.  Roles of host mitochondria in the development of COVID-19 pathology: Could mitochondria be a potential therapeutic target? , 2021, Molecular Biomedicine.

[57]  P. Reddy,et al.  Impact of COVID-19 on Mitochondrial-Based Immunity in Aging and Age-Related Diseases , 2021, Frontiers in Aging Neuroscience.

[58]  P. Cohen,et al.  Host mitochondrial transcriptome response to SARS-CoV-2 in multiple cell models and clinical samples , 2021, Scientific Reports.

[59]  A. Hussain,et al.  Determinants of in-hospital mortality in COVID-19; a prospective cohort study from Pakistan , 2021, medRxiv.

[60]  R. Pranata,et al.  Prognostic value of elevated lactate dehydrogenase in patients with COVID-19: a systematic review and meta-analysis , 2021, Postgraduate Medical Journal.

[61]  Tezcan Akın,et al.  Efficacy of the delta neutrophil index in predicting 30‐day mortality in COVID‐19 patients requiring intensive care , 2020, International journal of clinical practice.

[62]  E. Wood,et al.  Role of mitochondria, oxidative stress and the response to antioxidants in myalgic encephalomyelitis/chronic fatigue syndrome: A possible approach to SARS-CoV-2 ‘long-haulers’? , 2020, Chronic Diseases and Translational Medicine.

[63]  Amish Talwar,et al.  A Proposed Framework and Timeline of the Spectrum of Disease Due to SARS-CoV-2 Infection: Illness Beyond Acute Infection and Public Health Implications. , 2020, JAMA.

[64]  G. López-Lluch,et al.  Age-related mitochondrial dysfunction as a key factor in COVID-19 disease , 2020, Experimental Gerontology.

[65]  M. Mcphail,et al.  Mitochondrial metabolic manipulation by SARS-CoV-2 in peripheral blood mononuclear cells of patients with COVID-19 , 2020, American journal of physiology. Cell physiology.

[66]  V. Thiel,et al.  Coronavirus biology and replication: implications for SARS-CoV-2 , 2020, Nature Reviews Microbiology.

[67]  Z. Memish,et al.  Clinical Characteristics and Predictors of 28-Day Mortality in 352 Critically Ill Patients with COVID-19: A Retrospective Study , 2020, Journal of epidemiology and global health.

[68]  I. Dimopoulou,et al.  Lactate Kinetics Reflect Organ Dysfunction and Are Associated with Adverse Outcomes in Intensive Care Unit Patients with COVID-19 Pneumonia: Preliminary Results from a GREEK Single-Centre Study , 2020, Metabolites.

[69]  H. Nikzad,et al.  The novel coronavirus Disease-2019 (COVID-19): Mechanism of action, detection and recent therapeutic strategies , 2020, Virology.

[70]  S. Hussain,et al.  Burden of diabetes mellitus and its impact on COVID-19 patients: A meta-analysis of real-world evidence , 2020, Diabetes & Metabolic Syndrome: Clinical Research & Reviews.

[71]  B. Tang,et al.  Diabetes Mellitus is Associated with Severe Infection and Mortality in Patients with COVID-19: A Systematic Review and Meta-analysis , 2020, Archives of Medical Research.

[72]  Xiaochen Li,et al.  Abnormal immunity of non-survivors with COVID-19: predictors for mortality , 2020, Infectious Diseases of Poverty.

[73]  Wei Wang,et al.  Hyperglycemia is a strong predictor of poor prognosis in COVID-19 , 2020, Diabetes Research and Clinical Practice.

[74]  M. Antonelli,et al.  Prognostic factors associated with mortality risk and disease progression in 639 critically ill patients with COVID-19 in Europe: Initial report of the international RISC-19-ICU prospective observational cohort , 2020, EClinicalMedicine.

[75]  G. Chaubey,et al.  Decoding SARS-CoV-2 hijacking of host mitochondria in COVID-19 pathogenesis , 2020, American journal of physiology. Cell physiology.

[76]  F. Violi,et al.  COVID-19 and cardiovascular injury: A role for oxidative stress and antioxidant treatment? , 2020, International Journal of Cardiology.

[77]  D. Kokkinidis,et al.  Diabetes is associated with increased risk for in-hospital mortality in patients with COVID-19: a systematic review and meta-analysis comprising 18,506 patients , 2020, Hormones.

[78]  L. Delgado-Roche,et al.  Oxidative Stress as Key Player in Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) Infection , 2020, Archives of Medical Research.

[79]  Howard Y. Chang,et al.  RNA-GPS Predicts SARS-CoV-2 RNA Localization to Host Mitochondria and Nucleolus , 2020, bioRxiv.

[80]  Li Zhang,et al.  Summary of 20 tracheal intubation by anesthesiologists for patients with severe COVID-19 pneumonia: retrospective case series , 2020, Journal of Anesthesia.

[81]  Dong Men,et al.  Detectable Serum Severe Acute Respiratory Syndrome Coronavirus 2 Viral Load (RNAemia) Is Closely Correlated With Drastically Elevated Interleukin 6 Level in Critically Ill Patients With Coronavirus Disease 2019 , 2020, Clinical Infectious Diseases.

[82]  Kiran Bavirisetti Review of "A pneumonia outbreak associated with a new coronavirus of probable bat origin" , 2020 .

[83]  Xiang Li,et al.  On the origin and continuing evolution of SARS-CoV-2 , 2020, National science review.

[84]  Dong Men,et al.  Detectable serum SARS-CoV-2 viral load (RNAaemia) is closely correlated with drastically elevated interleukin 6 (IL-6) level in critically ill COVID-19 patients , 2020, medRxiv.

[85]  T. Jiang,et al.  The deadly coronaviruses: The 2003 SARS pandemic and the 2020 novel coronavirus epidemic in China , 2020, Journal of Autoimmunity.

[86]  Zunyou Wu,et al.  Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. , 2020, JAMA.

[87]  Yan Zhao,et al.  Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. , 2020, JAMA.

[88]  E. Holmes,et al.  A new coronavirus associated with human respiratory disease in China , 2020, Nature.

[89]  Kai Zhao,et al.  A pneumonia outbreak associated with a new coronavirus of probable bat origin , 2020, Nature.

[90]  E. Holmes,et al.  Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding , 2020, The Lancet.

[91]  Ting Yu,et al.  Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study , 2020, The Lancet.

[92]  G. Gao,et al.  A Novel Coronavirus from Patients with Pneumonia in China, 2019 , 2020, The New England journal of medicine.

[93]  Y. Hu,et al.  Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China , 2020, The Lancet.

[94]  S. Lo,et al.  A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster , 2020, The Lancet.

[95]  Yuan He,et al.  The NLRP3 Inflammasome: An Overview of Mechanisms of Activation and Regulation , 2019, International journal of molecular sciences.

[96]  Junbo Hu,et al.  Lactate Is a Natural Suppressor of RLR Signaling by Targeting MAVS , 2019, Cell.

[97]  Sachin Kumar,et al.  Organelle dynamics and viral infections: at cross roads , 2018, Microbes and Infection.

[98]  C. Claus,et al.  A renewed focus on the interplay between viruses and mitochondrial metabolism , 2013, Archives of Virology.

[99]  S. Tikoo,et al.  Viruses as Modulators of Mitochondrial Functions , 2013, Advances in virology.

[100]  S. Jameel,et al.  Severe acute respiratory syndrome coronavirus 3a protein activates the mitochondrial death pathway through p38 MAP kinase activation. , 2008, The Journal of general virology.

[101]  H. Majima,et al.  Evidence of ROS generation by mitochondria in cells with impaired electron transport chain and mitochondrial DNA damage. , 2007, Mitochondrion.

[102]  Umair Mallick Pathogenesis of CoViD19—Miscellaneous Mechanisms , 2022, Cardiovascular Complications of COVID-19.